CR20190161A - Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof - Google Patents
Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereofInfo
- Publication number
- CR20190161A CR20190161A CR20190161A CR20190161A CR20190161A CR 20190161 A CR20190161 A CR 20190161A CR 20190161 A CR20190161 A CR 20190161A CR 20190161 A CR20190161 A CR 20190161A CR 20190161 A CR20190161 A CR 20190161A
- Authority
- CR
- Costa Rica
- Prior art keywords
- conjugate
- composition
- same
- therapeutic use
- glucagon derivative
- Prior art date
Links
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical class C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 206010060378 Hyperinsulinaemia Diseases 0.000 abstract 1
- 208000013016 Hypoglycemia Diseases 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 abstract 1
- 201000008980 hyperinsulinism Diseases 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to a glucagon derivative, a conjugate thereof, a composition comprising the same and a use thereof and, more particularly, to a therapeutic use for the metabolic syndrome, hypoglycemia and concomitant hyperinsulinemia.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160182982 | 2016-12-29 | ||
| KR20170069217 | 2017-06-02 | ||
| PCT/KR2017/006922 WO2018004283A2 (en) | 2016-06-29 | 2017-06-29 | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20190161A true CR20190161A (en) | 2020-02-24 |
Family
ID=70917972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20190161A CR20190161A (en) | 2016-12-29 | 2017-06-29 | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR20190161A (en) |
-
2017
- 2017-06-29 CR CR20190161A patent/CR20190161A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018502742A1 (en) | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof | |
| CL2023000198A1 (en) | Glucagon derivative and a composition comprising a long-acting conjugate thereof | |
| ZA202007143B (en) | Pyridone derivative, composition thereof and application thereof as anti-influenza drug | |
| ZA201905098B (en) | A novel isoindoline derivative, a pharmaceutical composition and use thereof | |
| EP3254667A4 (en) | Light-curable composition, denture, and plate denture | |
| PH12017501084A1 (en) | Insulin glargine/lixisenatide fixed ratio formulation | |
| SG11201908281VA (en) | Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof | |
| MX2016013431A (en) | Pharmaceutical compositions comprising antibacterial agents. | |
| EP3156055A4 (en) | Pharmaceutical composition for preventing or treating muscular weakness-related diseases, containing butylpyridinium or derivative thereof | |
| EP3190129A4 (en) | Centrally-acting peptide derivative, and pharmaceutical composition | |
| PH12017501205A1 (en) | Glucagon derivatives | |
| SG11202003286YA (en) | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative | |
| PH12017502148A1 (en) | Pharmaceutical compositions and use thereof | |
| EA201991265A1 (en) | MEDICINAL FORMS WITH DELAYED DELIVERY CONTAINING DIMETHYLFUMARATE | |
| GB2543709A (en) | Pharmaceutical agent | |
| WO2016020408A3 (en) | Compounds for preventing ototoxicity | |
| PL3176164T3 (en) | Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same | |
| CR20190161A (en) | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof | |
| MX2016013428A (en) | Pharmaceutical compositions comprising antibacterial agents. | |
| WO2019203748A3 (en) | The composition comprising raloxifene with at least one antipsychotic agent | |
| EA201990011A1 (en) | GLUCAGON DERIVATIVE, CONJUGATE ON ITS BASIS, CONTAINING THEIR COMPOSITION AND THEIR THERAPEUTIC APPLICATION | |
| MX2016013979A (en) | New administration routes of insulin, insulin analogs or derivatives of insulin. | |
| IN2014CH01195A (en) | ||
| AU2017904853A0 (en) | Type 1 diabetes treatment | |
| AU2017903125A0 (en) | Type 1 Diabetes combination therapy |